REPLIGEN CORP - COMMON STOCK (RGEN)

Q4 2017 13F Holders as of 31 Dec 2017

Type / Class
Equity / COMMON STOCK
Shares outstanding
56,222,082
Number of holders
178
Total 13F shares, excl. options
37,859,448
Shares change
+1,390,942
Total reported value, excl. options
$1,373,622,569
Value change
+$48,489,524
Put/Call ratio
119%
Number of buys
93
Number of sells
84
Price
$36.28

Institutional Holders of REPLIGEN CORP - COMMON STOCK (RGEN) as of Q4 2017

As of 31 Dec 2017 REPLIGEN CORP - COMMON STOCK (RGEN) had 178 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions held a total of 37,859,448 shares of stock of the company.
Largest 10 holders included BlackRock Inc., Vanguard Group Inc, TimesSquare Capital Management, LLC, STATE STREET CORP, WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC, OppenheimerFunds, Inc., Conestoga Capital Advisors, LLC, Invesco Ltd., MACKENZIE FINANCIAL CORP, and DIMENSIONAL FUND ADVISORS LP.
This table shows 178 institutional shareholders of the security as of 31 Dec 2017.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.